跳至主要内容
临床试验/NCT02644200
NCT02644200已完成3 期

Gelatin Tannate as Treatment for Acute Childhood Gastroenteritis: a Prospective, Randomized, Single-blind Controlled Clinical Trial

University of Roma La Sapienza2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2013年6月1日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
60
试验地点
2
主要终点
Number of stools

研究概览

简要总结

Oral rehydration therapy is the only treatment recommended by the World Health Organization in acute diarrhea in children. The aim of this study was to compare the efficacy and safety of a therapy with gelatin tannate plus oral rehydration versus oral rehydration alone in children with acute gastroenteritis.

This is a single-blind, prospective, randomized and parallel study performed in two Pediatric Services of tertiary referral hospitals. Patients, ages 3 to 36 months with acute gastroenteritis randomized to receive an oral rehydration solution (OR), or an oral rehydration solution plus gelatin tannate (OR+G). The primary outcomes evaluated were: the number of bowel movements after 48 and 72 hours after initiating treatments. Secondary outcomes were: duration of diarrhea (days), stool characteristics and adverse events. Other clinical variables, as weight, fever, vomiting, appetite and the acceptability of the two treatments were also recorded.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
3 Months 至 5 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Children of both sex, aged 3 months to 5 years of age
  • Clinical diagnosis of acute gastroenteritis, as defined by having at least 3 loose stools within the previous 24 hours and/or a change in stool consistency to loose or liquid according to Bristol Stool Form Scale for Children (m-BSFS-C) lasting for no longer than 3 days.

排除标准

  • patients with gastroenteritis lasting more than 5 days
  • patients with chronic gastrointestinal conditions
  • patients receiving other antidiarrheal drugs within 2 weeks prior to enrollment (i.e. antibiotics, probiotics, salicylates, loperamide, racecadotril, disomectite)

结局指标

主要结局

Number of stools

时间窗: 48 hours

difference in the number of stools after treatment initiation in the 2 arms

次要结局

  • Growth(7 days)
  • Time to normalization of stool consistency(48 hours, 72 hours)
  • Adverse events treatment related(7 days)
  • Number of visits to the emergency room(7 days)
  • Duration of diarrhea after treatment initiation in the 2 arms(48 hours, 72 hours)

研究者

发起方
University of Roma La Sapienza
申办方类型
Other
责任方
Principal Investigator
主要研究者

Marina Aloi

MD, PhD

University of Roma La Sapienza

研究点 (2)

Loading locations...

相似试验